Portelius E - Search Results

1

Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer's disease.

Nilsson J, Ashton NJ, Benedet AL, Montoliu-Gaya L, Gobom J, Pascoal TA, Chamoun M, Portelius E, Jeromin A, Mendes M, Zetterberg H, Rosa-Neto P, Brinkmalm A, Blennow K. Nilsson J, et al. Among authors: portelius e. Alzheimers Res Ther. 2022 Jun 4;14(1):78. doi: 10.1186/s13195-022-01021-8. Alzheimers Res Ther. 2022. PMID: 35659284 Free PMC article.

2

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.

Portelius E, Westman-Brinkmalm A, Zetterberg H, Blennow K. Portelius E, et al. J Proteome Res. 2006 Apr;5(4):1010-6. doi: 10.1021/pr050475v. J Proteome Res. 2006. PMID: 16602710

3

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.

Portelius E, Zetterberg H, Andreasson U, Brinkmalm G, Andreasen N, Wallin A, Westman-Brinkmalm A, Blennow K. Portelius E, et al. Neurosci Lett. 2006 Dec 6;409(3):215-9. doi: 10.1016/j.neulet.2006.09.044. Epub 2006 Oct 17. Neurosci Lett. 2006. PMID: 17049739

4

Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment.

Thorsell A, Portelius E, Blennow K, Westman-Brinkmalm A. Thorsell A, et al. Among authors: portelius e. Rapid Commun Mass Spectrom. 2007;21(5):771-8. doi: 10.1002/rcm.2898. Rapid Commun Mass Spectrom. 2007. PMID: 17279600

5

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry.

Portelius E, Tran AJ, Andreasson U, Persson R, Brinkmalm G, Zetterberg H, Blennow K, Westman-Brinkmalm A. Portelius E, et al. J Proteome Res. 2007 Nov;6(11):4433-9. doi: 10.1021/pr0703627. Epub 2007 Oct 10. J Proteome Res. 2007. PMID: 17927230

6

A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.

Philipson O, Hammarström P, Nilsson KP, Portelius E, Olofsson T, Ingelsson M, Hyman BT, Blennow K, Lannfelt L, Kalimo H, Nilsson LN. Philipson O, et al. Among authors: portelius e. Neurobiol Aging. 2009 Sep;30(9):1393-405. doi: 10.1016/j.neurobiolaging.2007.11.022. Epub 2008 Jan 14. Neurobiol Aging. 2009. PMID: 18192084

7

Characterization of tau in cerebrospinal fluid using mass spectrometry.

Portelius E, Hansson SF, Tran AJ, Zetterberg H, Grognet P, Vanmechelen E, Höglund K, Brinkmalm G, Westman-Brinkmalm A, Nordhoff E, Blennow K, Gobom J. Portelius E, et al. J Proteome Res. 2008 May;7(5):2114-20. doi: 10.1021/pr7008669. Epub 2008 Mar 20. J Proteome Res. 2008. PMID: 18351740

8

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

Portelius E, Zetterberg H, Gobom J, Andreasson U, Blennow K. Portelius E, et al. Expert Rev Proteomics. 2008 Apr;5(2):225-37. doi: 10.1586/14789450.5.2.225. Expert Rev Proteomics. 2008. PMID: 18466053 Review.

9

Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.

Wasling P, Daborg J, Riebe I, Andersson M, Portelius E, Blennow K, Hanse E, Zetterberg H. Wasling P, et al. Among authors: portelius e. J Alzheimers Dis. 2009;16(1):1-14. doi: 10.3233/JAD-2009-0918. J Alzheimers Dis. 2009. PMID: 19158416 Review.

10

Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.

Portelius E, Brinkmalm G, Tran AJ, Zetterberg H, Westman-Brinkmalm A, Blennow K. Portelius E, et al. Neurodegener Dis. 2009;6(3):87-94. doi: 10.1159/000203774. Epub 2009 Feb 20. Neurodegener Dis. 2009. PMID: 19229112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters